MedPath

国药控股星鲨制药(厦门)有限公司

Ownership
-
Established
1998-12-30
Employees
-
Market Cap
-
Website
http://www.xingsha.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

259

NMPA:259

Drug Approvals

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H35020819
Approval Date
Mar 6, 2025
NMPA

Piroxicam Tablets

Product Name
吡罗昔康片
Approval Number
国药准字H35020785
Approval Date
Feb 10, 2025
NMPA

Glycerol

Product Name
甘油
Approval Number
国药准字H35020204
Approval Date
Jan 2, 2025
NMPA

Vardenafil Hydrochloride Tablets

Product Name
盐酸伐地那非片
Approval Number
国药准字H20249431
Approval Date
Nov 22, 2024
NMPA

Clozapine Tablets

Product Name
氯氮平片
Approval Number
国药准字H35020914
Approval Date
Apr 7, 2020
NMPA

Vitamin D2 Pills

Product Name
维生素D2丸
Approval Number
国药准字H35021558
Approval Date
Apr 7, 2020
NMPA

Carbazochrome Tablets

Product Name
肾上腺色腙片
Approval Number
国药准字H35020920
Approval Date
Apr 7, 2020
NMPA

Erythromycin Estolate Tablets

Product Name
依托红霉素片
Approval Number
国药准字H35020828
Approval Date
Apr 7, 2020
NMPA

Levamisole Hydrochloride Tablets

Product Name
盐酸左旋咪唑片
Approval Number
国药准字H35020844
Approval Date
Apr 7, 2020
NMPA

消痰咳片

Approval Number
国药准字Z35020028
Approval Date
Apr 7, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 26
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.